These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 28350539

  • 1. Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.
    Kylat RI, Senguttuvan R, Bader MY.
    J Pediatr Endocrinol Metab; 2017 May 01; 30(5):593-596. PubMed ID: 28350539
    [Abstract] [Full Text] [Related]

  • 2. Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant.
    Siklar Z, Ellard S, Okulu E, Berberoğlu M, Young E, Savaş Erdeve S, Mungan IA, Hacihamdioğlu B, Erdeve O, Arsan S, Oçal G.
    J Pediatr Endocrinol Metab; 2011 May 01; 24(11-12):1077-80. PubMed ID: 22308870
    [Abstract] [Full Text] [Related]

  • 3. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.
    Mancioppi V, Pozzi E, Zanetta S, Missineo A, Savastio S, Barbetti F, Mellone S, Giordano M, Rabbone I.
    Front Endocrinol (Lausanne); 2023 May 01; 14():1143736. PubMed ID: 37251668
    [Abstract] [Full Text] [Related]

  • 4. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of KATP-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital.
    Ngoc CTB, Dien TM, De Franco E, Ellard S, Houghton JAL, Lan NN, Thao BP, Khanh NN, Flanagan SE, Craig ME, Dung VC.
    Front Endocrinol (Lausanne); 2021 May 01; 12():727083. PubMed ID: 34566892
    [Abstract] [Full Text] [Related]

  • 5. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.
    Li X, Xu A, Sheng H, Ting TH, Mao X, Huang X, Jiang M, Cheng J, Liu L.
    Pediatr Diabetes; 2018 Mar 01; 19(2):251-258. PubMed ID: 28791793
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
    Mak CM, Lee CY, Lam CW, Siu WK, Hung VC, Chan AY.
    Diagn Mol Pathol; 2012 Mar 01; 21(1):56-9. PubMed ID: 22306677
    [Abstract] [Full Text] [Related]

  • 8. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
    Taberner P, Flanagan SE, Mackay DJ, Ellard S, Taverna MJ, Ferraro M.
    Diabetes Res Clin Pract; 2016 Jul 01; 117():104-10. PubMed ID: 27329029
    [Abstract] [Full Text] [Related]

  • 9. Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
    Hashimoto Y, Dateki S, Hirose M, Satomura K, Sawada H, Mizuno H, Sugihara S, Maruyama K, Urakami T, Sugawara H, Shirai K, Yorifuji T.
    Pediatr Diabetes; 2017 Nov 01; 18(7):532-539. PubMed ID: 27681997
    [Abstract] [Full Text] [Related]

  • 10. KCNJ11 in-frame 15-bp deletion leading to glibenclamide-responsive neonatal diabetes mellitus in a Chinese child.
    Yang W, Wei H, Sang Y.
    J Pediatr Endocrinol Metab; 2013 Nov 01; 26(7-8):743-6. PubMed ID: 24266052
    [Abstract] [Full Text] [Related]

  • 11. KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child.
    Yang W, Wei H, Sang Y.
    J Pediatr Endocrinol Metab; 2013 Nov 01; 26(5-6):591-4. PubMed ID: 23640936
    [Abstract] [Full Text] [Related]

  • 12. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
    Bremer AA, Ranadive S, Lustig RH.
    Pediatr Diabetes; 2008 Jun 01; 9(3 Pt 1):236-9. PubMed ID: 18221420
    [Abstract] [Full Text] [Related]

  • 13. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.
    Tonini G, Bizzarri C, Bonfanti R, Vanelli M, Cerutti F, Faleschini E, Meschi F, Prisco F, Ciacco E, Cappa M, Torelli C, Cauvin V, Tumini S, Iafusco D, Barbetti F, Early-Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology.
    Diabetologia; 2006 Sep 01; 49(9):2210-3. PubMed ID: 16816952
    [No Abstract] [Full Text] [Related]

  • 14. Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation.
    Wambach JA, Marshall BA, Koster JC, White NH, Nichols CG.
    Pediatr Diabetes; 2010 Jun 01; 11(4):286-8. PubMed ID: 19656320
    [Abstract] [Full Text] [Related]

  • 15. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
    Ješić MM, Ješić MD, Maglajlić S, Sajić S, Necić S.
    Diabetes Res Clin Pract; 2011 Jan 01; 91(1):e1-3. PubMed ID: 21056492
    [Abstract] [Full Text] [Related]

  • 16. Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype.
    Garcin L, Mericq V, Fauret-Amsellem AL, Cave H, Polak M, Beltrand J.
    Pediatr Diabetes; 2020 Sep 01; 21(6):932-941. PubMed ID: 32418263
    [Abstract] [Full Text] [Related]

  • 17. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.
    Greeley SA, Naylor RN, Philipson LH, Bell GI.
    Curr Diab Rep; 2011 Dec 01; 11(6):519-32. PubMed ID: 21993633
    [Abstract] [Full Text] [Related]

  • 18. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
    Jahnavi S, Poovazhagi V, Mohan V, Bodhini D, Raghupathy P, Amutha A, Suresh Kumar P, Adhikari P, Shriraam M, Kaur T, Das AK, Molnes J, Njolstad PR, Unnikrishnan R, Radha V.
    Clin Genet; 2013 May 01; 83(5):439-45. PubMed ID: 22831748
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
    Bowman P, Sulen Å, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, Flanagan SE, Babiker T, Thomas NJ, Shepherd MH, Ellard S, Klimes I, Szopa M, Polak M, Iafusco D, Hattersley AT, Njølstad PR, Neonatal Diabetes International Collaborative Group.
    Lancet Diabetes Endocrinol; 2018 Aug 01; 6(8):637-646. PubMed ID: 29880308
    [Abstract] [Full Text] [Related]

  • 20. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.
    Babiker T, Vedovato N, Patel K, Thomas N, Finn R, Männikkö R, Chakera AJ, Flanagan SE, Shepherd MH, Ellard S, Ashcroft FM, Hattersley AT.
    Diabetologia; 2016 Jun 01; 59(6):1162-6. PubMed ID: 27033559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.